Hydroxychloroquine does not increase the risk of arrhythmia, a large study in Arthritis & Rheumatology has found. The study was precipitated by controversy surrounding hydroxychloroquine and a ...
Introduction The increasing incidence of type 2 diabetes mellitus (T2DM) among women of reproductive age poses significant health risks for both mothers and their fetuses. Optimising blood glucose ...
Current use of hydroxychloroquine is associated with a lower risk for myocardial infarction (MI), stroke, and other thromboembolic events in patients with systemic lupus erythematosus (SLE). This ...
A new study found a connection between lower doses of hydroxychloroquine (HCQ) and increased risk of hospitalization in people with active systemic lupus erythematosus (SLE). HCQ (known commercially ...
Iowans will be able to weigh in on the bill during a public subcommittee hearing scheduled for Tuesday at 12:15 p.m. in Room ...
A state lawmaker wants the South Dakota Legislature to address how ivermectin and hydroxychloroquine are dispensed to ...
Hydroxychloroquine use may lower the risk for new-onset diabetes among patients with primary Sjögren syndrome. Hydroxychloroquine (HCQ) use significantly lowers the risk for new-onset diabetes among ...
Hydroxychloroquine exposure in patients with lupus nephritis was associated with a substantially lower risk for estimated glomerular filtration rate (eGFR) decline of ≥ 30%, particularly among those ...
The optimal hydroxychloroquine blood level in lupus is between 750 ng/mL and 1,150 ng/mL, which can help prevent active ...
A discredited study that set off a flurry of interest in using an antimalarial drug to treat COVID-19 has now been formally withdrawn. A scientific journal on Tuesday retracted the March 2020 study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results